TXG 10x Genomics Inc: רווח נקי למניה ב-12 החודשים האחרונים

10x Genomics, Inc. (TXG) dominates spatial biology by creating benchmark tools for genetics. High-margin consumables ensure a steady cash flow. Tracking the rolling year-over-year EPS chart on GURU.Markets, we note that this metric equals 16.70. The company's success is bolstered by professional management, which effectively protects intellectual property and controls the share ownership structure.
פילוחי מדדים פיננסיים ומדדי שוק עבור 10x Genomics, Inc. (TXG)

The 10x Genomics, Inc. (TXG) business combines high-precision robotic instrument assembly with the intellectual labor of scientists in reagent development. The trailing twelve months (TTM) net income per share dynamics measure the rate of change in return on equity, allowing investors to assess business sustainability and avoid overpaying for control by analyzing the history of EPS YoY (TTM) percentage changes.